There was little mystery in seeing SonoSite (Nasdaq:SONO) get an acquisition bid. Not only has this relatively small manufacturer of portable ultrasound systems been a logical target for years, but the company began to actively and explicitly sell itself starting back in November. In a week that has seen another logical target (Synovis (Nasdaq:SYNO) get a bid from a not-so-likely buyer (Baxter (NYSE:BAX), the fact that it was Japan's Fujifilm that stepped up to buy the company makes this an a somewhat unusual story.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

The Deal
Fujifilm will be acquiring SonoSite for $995 million in cash, or about $54 per share. That's a 28% premium to Wednesday night's close and a 75% premium to the price of SonoSite's stock before it was widely known that the company was looking to sell. SonoSite is going out at a little more than three times trailing revenue, a multiple curiously similar to that of Synovis and one that is not all that robust by historical small-cap med-tech standards, but isn't so unreasonable given the performance of the company. (For related reading, see An Introduction To Small Cap Stocks.)

What Fujifilm is Getting
To SonoSite's credit, it managed to carve an almost 40% market share in the portable ultrasound market while competing with the giant General Electric (NYSE:GE) (which holds about 50% share). There's been ample litigation between the two companies for years, but SonoSite was able to make a name for itself with solid technology, good product features and a pure commitment to the portable market.

SonoSite basically succeeded by being willing to swim against the tide. While companies like GE, Siemens (NYSE:SI) and Phillips (NYSE:PHG) were hard at work developing more powerful "Big Iron" ultrasound systems for radiology departments, SonoSite saw the opportunity in point-of-care imaging. It would be inaccurate to say that SonoSite's hand-carried systems are just as good as the state-of-art installed systems, but that's not the point. Just as armies find use for both small arms and heavy artillery, so too are there appropriate times and places for both types of imaging systems.

Interestingly, although SonoSite has shown very impressive revenue growth over its many years, would-be rivals like Siemens, Phillips and Mindray (NYSE:MR) have never established any serious presence in this segment.

Wait A Minute ... Fujifilm?
Investors may be surprised to see Fujifilm stepping up to buy this company. After all, Fujifilm is still best known in the United States for its photographic film and its iconic green color schemes. While Fujifilm most definitely has its heritage in photographic film, the company has been very active in diversifying its business in recent years so as to avoid the fate of Polaroid and Eastman Kodak.

To that end, Fujifilm has targeted healthcare as an area of focus. In addition to legacy businesses in somewhat logical fields like X-ray systems and film, Fujifilm has looked for ways to leverage technological capabilities like control technology for chemicals and various production and analytical controls. Recently, in fact, Fujifilm formed a joint venture with Kyowa Hakko Kirin to produce biosimilar pharmaceuticals (basically generic versions of antibody therapies like Abbott's (NYSE:ABT) Humira).

The Bottom Line
Relative to the market today, SonoSite shareholders are getting a respectable deal. Yes, there is real potential in new products like the high-end Edge and the market for portable ultrasound is still under-penetrated. But it was not as though SonoSite was tearing up the market recently by its own efforts.

Given how long SonoSite was rumored to be on the block, it seems fair to assume that its bankers shopped this company to every logical buyer out there - including Siemens, Phillips, Samsung and perhaps even other Japanese companies like Hitachi or Olympus. Fujifilm's offer is likely the best that investors can, or should, expect. (For related reading, see Analyzing An Acquisition Announcement.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Stephen Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Will WYNN Continue to Rally?

    Wynn Resorts has experienced a rally recently. Will it remain a good bet?
  2. Stock Analysis

    Don't Be Fooled by the Market's Recent Rally

    The bulls won for a bit in early October, but will bears have the last laugh?
  3. Stock Analysis

    Will Twitter's Stock Find its Wings Soon?

    Twitter is an enigma to many investors, but its story is pretty straightforward.
  4. Stock Analysis

    8 Solid Utility Stocks for a Bear Market

    If you're seeking modest appreciation, generous dividend payments and resiliency, consider these eight utility stocks.
  5. Stock Analysis

    Why Phillips 66 (PSX) is a Solid Long-Term Bet

    Here's why Phillips 66 will likely remain one of the world’s largest and most profitable companies for a long time to come.
  6. Stock Analysis

    3 Resilient Oil Stocks for a Down Market

    Stuck on oil? Take a look at these six stocks—three that present risk vs. three that offer some resiliency.
  7. Economics

    Keep an Eye on These Emerging Economies

    Emerging markets have been hammered lately, but these three countries (and their large and young populations) are worth monitoring.
  8. Stock Analysis

    Is Pepsi (PEP) Still a Safe Bet?

    PepsiCo has long been known as one of the most resilient stocks throughout the broader market. Is this still the case today?
  9. Investing

    The ABCs of Bond ETF Distributions

    How do bond exchange traded fund (ETF) distributions work? It’s a question I get a lot. First, let’s explain what we mean by distributions.
  10. Stock Analysis

    The 5 Best Dividend Stocks in the Healthcare Sector

    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash flows to afford high payouts.
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!